Yingxin Wang
Guang Zhou Road 264
Nanjing, 210029, China
Nanjing, 210029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Radiotherapy-synergized in situ hydrogel vaccine with engineered Lactococcus lactis FOLactis potentiates anti-tumor immunity in pancreatic cancer.
Journal: Frontiers in immunology
Published: January 16, 2026
Correction: Tumor-penetrating peptide boosts bispecific T-cell engager antitumor efficacy for the pancreatic cancer.
Journal: Frontiers in immunology
Published: December 22, 2025
Tumor-penetrating peptide boosts bispecific T-cell engager antitumor efficacy for the pancreatic cancer.
Journal: Frontiers in immunology
Published: August 27, 2025
An Immunomodulator-Boosted Lactococcus Lactis Platform For Enhanced In Situ Tumor Vaccine.
Journal: Advanced healthcare materials
Published: May 03, 2024
Acidity-targeting transition-aided universal chimeric antigen receptor T-cell (ATT-CAR-T) therapy for the treatment of solid tumors.
Journal: Biomaterials
Published: November 22, 2023
Influencing electroclinical features and prognostic factors in patients with anti-NMDAR encephalitis: a cohort follow-up study in Chinese patients.
Journal: Scientific reports
Published: December 12, 2019
Altered cerebral blood flow in patients with anti-NMDAR encephalitis.
Journal: Journal of neurology
Published: November 19, 2019
Ictal Source Locations and Cortico-Thalamic Connectivity in Childhood Absence Epilepsy: Associations with Treatment Response.
Journal: Brain topography
Published: April 06, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026